1. Qureshi K, Abrams GA. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2007;13:3540–53.
2. [Internet] World Health Organization, Global health observatory (GHO) data. http://www.who.int/gho/ncd/risk_factors/obesity_text/en/index.html . Accessed 7 Jan 2017.
3. Artham SM, Lavie CJ, Milani RV, Ventura HO. The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad Med. 2008;120:34–41.
4. Pagotto U, Vanuzzo D, Vicennati V, Pasquali R. Pharmacological therapy of obesity. Ital J Cardiol. 2008;9:83–93.
5. Fried M, Hainer V, Basdevant A, Buchwald H, Dietel M, Finer N, Greve JW, Horber F, Mathus-Vliegen E, Scopinaro N, Steffen R, Tsigos C, Weiner R, Widhalm K. Interdisciplinary European guidelines on surgery for severe obesity. Rozhl Chir. 2008;87:468–76.